Approval · Notice of Compliance 4797 · 2004
PARIET: Notice of Compliance 4797
Issued July 16, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4797
- Date
- July 16, 2004
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of symptoms in symptomatic gastroesophageal reflux disease (gerd), also called non-erosive reflux disease (nerd)
- Therapeutic class
- H+, k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PARIET | Not yet assigned | — |
Medicinal ingredients
- RABEPRAZOLE SODIUM 10 MG per TAB
- RABEPRAZOLE SODIUM 20 MG per TAB